Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF)
Learn More About This Topic: Chat with Us | Email Us
Phase II Study of Paclitaxel, Oxaliplatin, Leucovorin and 5-Fluorouracil (POLF) in Gemcitabine-Refractory Advanced Pancreatic Cancer
Summary
The purpose of this study is to determine the effectiveness of this combination of chemotherapy drugs for the treatment of advanced pancreatic cancer.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.
